HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Pituitary carcinomas: review of the current literature and report of atypical case.

Abstract
Introduction: Pituitary carcinomas are poorly understood, rare entities. They are distinguished from adenomas not by histopathological features but rather by the presence of metastases.Objective: We discuss the diagnosis, mechanism of dissemination and pathogenesis based on a review of the literature and illustrated by a singular case.Case Report: A 59-year-old male presented with a dural-based posterior fossa lesion. He had been diagnosed with a pituitary chromophobe adenoma 43 years earlier that was treated at the time with surgery and radiation therapy. A presumptive diagnosis of a radiation-induced meningioma was made and surgery was recommended. At surgery the tumour resembled a pituitary adenoma. Histopathology, laboratory findings, and the patient's medical history confirmed the final diagnosis of a prolactin-secreting pituitary carcinoma. To our knowledge, this is the longest reported interval between the pituitary adenoma and metastatic lesion diagnosis (43 years).Conclusion: Management should be tailored to individual patient and may include a combination of treatments (surgery, radiation therapy, chemotherapy, and hormone-targeted therapy). Functionally active tumours may be monitored with hormone levels as tumour markers.
AuthorsAlexandre B Todeschini, André Beer-Furlan, Alaa S Montaser, Ali O Jamshidi, Luma Ghalib, Jesus A Chavez, Norman L Lehman, Daniel M Prevedello
JournalBritish journal of neurosurgery (Br J Neurosurg) Vol. 34 Issue 5 Pg. 528-533 (Oct 2020) ISSN: 1360-046X [Electronic] England
PMID30836020 (Publication Type: Case Reports, Journal Article)
Topics
  • Adenoma (diagnosis, surgery)
  • Humans
  • Male
  • Middle Aged
  • Neoplasms, Radiation-Induced
  • Pituitary Neoplasms (diagnostic imaging, surgery)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: